MedElevator Войти в исследования
← Поиск публикаций
Journal of the American College of Cardiology · 2026

2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

СтатьяКлинические рекомендацииНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Blumenthal Roger S, Morris Pamela B, Gaudino Mario, Johnson Heather M, Anderson Timothy S, Bittner Vera A, Blankstein Ron, Brewer LaPrincess C, Cho Leslie, de Ferranti Sarah D, Gianos Eugenia, Gluckman Ty J, Gradney Kristen F, Isiadinso Ijeoma, Lloyd-Jones Donald M, Marrs Joel C, Martin Seth S, McLain Kellie H, Mehta Laxmi S, Mora Samia, Mulugeta Wudeneh M, Natarajan Pradeep, Navar Ann Marie, Orringer Carl E, Polonsky Tamar S, Reynolds Harmony R, Saseen Joseph J, Shapiro Michael D, Soffer Daniel E, Tynes Sheila A, Villavaso Chloé D, Virani Salim S, Wilkins John T

Аннотация

AIM: The "2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia" retires and replaces the "2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol."

METHODS: A comprehensive literature search was conducted from October 2024 to December 2024 to identify clinical studies, systematic reviews and meta-analyses, and other evidence conducted on human participants that were published in English from MEDLINE (through PubMed), EMBASE, the Cochrane Library, Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline.

STRUCTURE: The focus of this clinical practice guideline is to address the evaluation, management, and monitoring of individuals with dyslipidemias, including high blood cholesterol, hypertriglyceridemia, and elevated lipoprotein(a).

Предметные рубрики MeSH